This website uses cookies to ensure you get the best experience on our website.
- Table of Contents

SMARCA2 antibody (A01888-3) performs well in ELISA, Flow Cytometry, IF, IHC, ICC, WB and shows reactivity with Human, Mouse, Rat.
| Reactive Species | Host | Application |
|---|---|---|
| Human, Mouse, Rat | Rabbit | ELISA, Flow Cytometry, IF, IHC, ICC, WB |
SMARCA2 antibody was positively detected by WB in:
human U20S whole cell, human A549- WT whole cell, human A549-SMARCA2 KO whole cell, rat PC-12 whole cell, mouse RAW2647 whole cell
Suggested blocking solution with 5% non-fat milk or BSA; (*)Recommended protein loading: 20-40 ug per lane
SMARCA2 antibody was positively detected by IHC in:
human appendix adenocarcinoma tissue, human breast cancer tissue, human colon adenocarcinoma tissue, human diffuse large B cell lymphoma tissue, human esophageal squamous carcinoma tissue, human glioblastom tissue, human placenta tissue, human prostate adenocarcinoma tissue, human right renal oncocytoma tissue, human spleen tissue, human thyroid papillary carcinoma tissue, human urothelial carcinoma tissue
Use TE buffer pH 9.0 for antigen retrieval; (*) citrate buffer pH 6.0 is an alternative.
SMARCA2 antibody was positively detected by ICC/IF in:
A549 cell
SMARCA2 antibody was positively detected by FC in:
THP-1 cell
* It is recommended to optimize the amount of this reagent in each experimental system to achieve the best results.
Note: For flow cytometry (FCM), validated for fixed cells only. Not validated for FACS or surface flow cytometry using live cells.
181.3 kDa
Submit a review and receive $370 in product credits, a $185 Amazon gift card, or our carefully curated gift bundles.
We promise Anti-SMARCA2/BRM Antibody Picoband® performs excellently in relevant applications for ELISA, Flow Cytometry, IF, IHC, ICC, WB. If it doesn't perform as promised, we will refund the product. Learn more
We promise all of our products perform as described in datasheets.
This product is for Research Use Only. Not for use in diagnostic procedures.